Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model

Combination therapy is an attractive therapeutic option for extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. Colistin has been the only treatment available for these infections for many years, but its results are suboptimal. Ceftolozane-tazobactam (C/T) is a newly available therap...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Antimicrob Agents Chemother
Main Authors: Montero, María, Domene Ochoa, Sandra, López-Causapé, Carla, VanScoy, Brian, Luque, Sonia, Sorlí, Luisa, Campillo, Núria, Angulo-Brunet, Ariadna, Padilla, Eduardo, Prim, Núria, Pomar, Virginia, Rivera, Alba, Grau, Santiago, Ambrose, Paul G., Oliver, Antonio, Horcajada, Juan P.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2020
נושאים:
Experimental Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179322/
https://ncbi.nlm.nih.gov/pubmed/32041712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02542-19
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים